![](/img/cover-not-exists.png)
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results
le Coutre, P D, Giles, F J, Hochhaus, A, Apperley, J F, Ossenkoppele, G J, Blakesley, R, Shou, Y, Gallagher, N J, Baccarani, M, Cortes, J, Kantarjian, H MVolume:
26
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2011.323
Date:
June, 2012
File:
PDF, 326 KB
english, 2012